Zydus Cadila gets approval from USFDA for breast cancer drug

Posted on:07 Oct 2018 09:00:01
Zydus Cadila gets approval from USFDA for breast cancer drug
07 October 2018 Current Affairs:

Zydus Cadila, the major drug firm, has received the final approval from the U.S. Food and Drug Administration (USFDA) to market Exemestane tablets. The drug will be used for the treatment of breast cancer. The drug is made in the strength of 25 mg. The company will manufacture the drug at its group’s formulations SEZ facility in Ahmedabad.


Zydus Cadila, the major drug firm, has received the final approval from the U.S. Food and Drug Administration (USFDA) to market Exemestane tablets. The drug will be used for the treatment of breast cancer. The drug is made in the strength of 25 mg. The company will manufacture the drug at its group’s formulations SEZ facility in Ahmedabad.


Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Currentt Affairs 2018 November

15 NOVEMBER
NEWS
14 NOVEMBER
NEWS
13 NOVEMBER
NEWS
12 NOVEMBER
NEWS

Currentt Affairs 2018 October

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Currentt Affairs 2018 September

30 SEPTEMBER
NEWS
29 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS